Prospectively validated augmented intelligence for disease-agnostic predictions of clinical success for novel therapeutics

Bragi Lovetrue, Idonae Lovetrue
doi: https://doi.org/10.1101/2022.03.14.22272372

Article Information

doi 
https://doi.org/10.1101/2022.03.14.22272372
History 
  • April 11, 2022.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Bragi Lovetrue1,*,† and
  2. Idonae Lovetrue1,†
  1. 1Demiurge Technologies AG, Baarerstrasse 14 6300 Zug Switzerland
  1. ↵*Corresponding author. Email: bragi{at}demiurge.ch
Back to top
Posted April 11, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Prospectively validated augmented intelligence for disease-agnostic predictions of clinical success for novel therapeutics
Bragi Lovetrue, Idonae Lovetrue
medRxiv 2022.03.14.22272372; doi: https://doi.org/10.1101/2022.03.14.22272372
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area